Upcoming treatments for morphea
Abstract Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4–2.7 cases per 100,000. Morphea occurs most frequently in children aged 2–14 years, and the disease exhibits a female predominance. Insights in...
Guardado en:
Autores principales: | Dan Wenzel, Nazgol‐Sadat Haddadi, Khashayar Afshari, Jillian M. Richmond, Mehdi Rashighi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c979b079617a4b38afa6c44a5b637f4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Progesterone Aggravates Lung Fibrosis in a Mouse Model of Systemic Sclerosis
por: Fatemeh Vafashoar, et al.
Publicado: (2021) -
Сatalase antibodies in patients with systemic scleroderma as a diagnostic and prognostic marker of the disease
por: O. I. Emelyanova, et al.
Publicado: (2021) -
DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
por: O. I. Emelyanova, et al.
Publicado: (2019) -
PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1
por: Naoko Takamura, et al.
Publicado: (2021) -
Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137+ FOXP3+ Regulatory T Cells Detectable in Peripheral Blood
por: Yi Zhang, et al.
Publicado: (2021)